Microsoft’s MSFT-2.58%decrease; red down pointing triangle Copilot chatbot has become central to its artificial-intelligence strategy as the company’s close partnership with OpenAI diminishes. But the ...

I tend to divide my workday into blocks. Within minutes of waking up — we’re usually up by 5.30 a.m. — I sit down to write at least one Inc. article. Then I spend four to five hours writing a book, ...

Singapore, Jan. 21, 2026 (GLOBE NEWSWIRE) -- In a major step forward for AI-driven business solutions, Simplex AI today announced it has secured $6 million in funding from GL Ventures to accelerate ...

The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...

Bluetooth is a technology for short-range data transmission that has become so ubiquitous in recent years that we can no longer imagine life without it. This makes it all the more annoying when ...

During an interview with The New York Times, Stewart was asked about method acting after the conversation turned to Marlon Brando’s work on “Superman: The Movie.” The legendary actor reportedly would ...

Cognitive struggles are climbing across the U.S., especially among young and economically disadvantaged adults. Rates of self-reported cognitive disability nearly doubled in people under 40 between ...

We may receive a commission on purchases made from links. Technology, no matter how advanced it is, is never perfect. With every type of smart device or gadget comes some sort of issue that users have ...

That’s how Meta’s chief AI scientist Yann LeCun described the blowback after OpenAI researchers did a victory lap over GPT-5’s supposed math breakthroughs. Google DeepMind CEO Demis Hassabis added, ...

The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...

ROOTSTOWN, Ohio--(BUSINESS WIRE)--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, ...